Revision as of 16:14, 16 August 2005 editRmky87 (talk | contribs)Extended confirmed users16,215 editsNo edit summary← Previous edit | Revision as of 16:15, 16 August 2005 edit undoRmky87 (talk | contribs)Extended confirmed users16,215 edits removed redundant imageNext edit → | ||
Line 1: | Line 1: | ||
{| border="1" cellpadding="3" cellspacing="0" width="250px" align="right" style="border-collapse: collapse; margin: 0 0 0 0.5em" | {| border="1" cellpadding="3" cellspacing="0" width="250px" align="right" style="border-collapse: collapse; margin: 0 0 0 0.5em" | ||
|- | |- | ||
| bgcolor="#ffffff" align="center" colspan="2" | | | bgcolor="#ffffff" align="center" colspan="2" | | ||
]<br/> | ]<br/> | ||
''{{PAGENAME}}'' | ''{{PAGENAME}}'' | ||
|- | |- | ||
Line 38: | Line 37: | ||
| bgcolor="#ddeeff" | ? | | bgcolor="#ddeeff" | ? | ||
|} | |} | ||
] | |||
'''Duloxetine hydrochloride''' (brand name: '''Cymbalta''') is a medically used drug that primarily targets major ] disorders (MDD) and stress urinary incontinence (SUI). Known also as LY248686, chemically (+)-(''S'')-''N''-methyl-3-(1-naphthyloxy)-2-thiophenepropanamine, it is a potent dual inhibitor of ] (5-hydroxytryptamine, 5-HT) and ] (NE) reuptake, possessing comparable affinities in binding to NE and 5-HT transport sites. Interestingly, its behavior contrasts to most other dual-reuptake inhibitors. | '''Duloxetine hydrochloride''' (brand name: '''Cymbalta''') is a medically used drug that primarily targets major ] disorders (MDD) and stress urinary incontinence (SUI). Known also as LY248686, chemically (+)-(''S'')-''N''-methyl-3-(1-naphthyloxy)-2-thiophenepropanamine, it is a potent dual inhibitor of ] (5-hydroxytryptamine, 5-HT) and ] (NE) reuptake, possessing comparable affinities in binding to NE and 5-HT transport sites. Interestingly, its behavior contrasts to most other dual-reuptake inhibitors. | ||
Revision as of 16:15, 16 August 2005
IUPAC chemical name | |
CAS number ? |
ATC code ? |
Chemical formula | ? |
Molecular weight | ? |
Bioavailability | ? |
Metabolism | ? |
Elimination half-life | ? |
Excretion | ? |
Pregnancy category | ? |
Legal status | ? |
Routes of administration | ? |
Duloxetine hydrochloride (brand name: Cymbalta) is a medically used drug that primarily targets major depressive disorders (MDD) and stress urinary incontinence (SUI). Known also as LY248686, chemically (+)-(S)-N-methyl-3-(1-naphthyloxy)-2-thiophenepropanamine, it is a potent dual inhibitor of serotonin (5-hydroxytryptamine, 5-HT) and norepinephrine (NE) reuptake, possessing comparable affinities in binding to NE and 5-HT transport sites. Interestingly, its behavior contrasts to most other dual-reuptake inhibitors.
Furthermore, duloxentine lacks affinity for monoamine receptors within the central nervous system. While there is limited data available regarding the pharmacokinetic profile of duloxetine in humans, its half-life is reported to be 10 to 15 hours.
External links
- Manufacturer website
- Duloxetine - medlineplus.org
This medical treatment–related article is a stub. You can help Misplaced Pages by expanding it. |